Abstract
Lead is found in small but appreciable quantities in air, soil drinking water and food. Exposure to such amounts of lead does not cause acute lead toxicity, but produces subtle effects, particularly in children. The CDC advocates “safe” or “acceptable” levels of blood lead up to 10 μg/dl, while OSHA declares blood lead levels up to 40 μg/dl as “safe” or “acceptable” in the occupationally exposed. The objective of the study was to see if blood levels considered “safe” can cause changes in the biogenic neurotransmitters in the developing brain which may cause neurobehavioral defects like hyperactivity and other cognitive disorders. Albino Wistar rats were divided into the control and lead-treated groups. The control group was given unleaded water, while the lead-treated group was fed with 50 ppm lead acetate in drinking water. On day 45 the animals were subjected to a passive avoidance test, their blood analysed for ZPP and lead. They were then sacrificed and the neurotransmitters—Norepinephrine (NE) and its metabolite—methoxyhydroxyphenylglycol (MHPG) estimated in the brain areas associated with learning and memory—the frontal cortex, hippocampus and the striatum by HPLC-ECD. Our results showed significant increases in blood lead, NE and MHPG, while ZPP increase was insignificant. The rats showed neurobehavioral abnormalities as assessed by the passive avoidance test. We concluded that low blood levels of lead cannot be considered “safe” or “acceptable” as it causes neurotransmitter alterations. Increased NE turnover is implicated in hyperactivity disorders such as ADHD and Tourette syndrome.
Similar content being viewed by others
Abbreviations
- CDC:
-
Centre for Disease Control
- OSHA:
-
Occupational Safety and Health Administration
- NE:
-
Norepinephrine
- MHPG:
-
3-Methoxy-4-hydroxyl phenyl glycol
- ZPP:
-
Zinc protoporphyrin
References
Wong GP, Timothy L, Martin TR, Farquharson DF. Effects of low lead exposure in utero. Obstet Gynecol Surv. 1992;47(5):285–8.
Borschein RL, Succop PA, Dietrich KN, Clark CS, Que-Hee S, Hammond PB. The influence of social and economical factors on dust lead, hand lead and blood lead levels in young children. Environ Res. 1985;38(1):108–18.
Barton JC, Conrad ME, Harrison L, Nuby S. Effects of calcium on the absorption and retention of lead. J Lab Clin Med. 1978;91(3):366–76.
IPCS Environmental Health criteria 165, Inorganic Lead. WHO Publication. 1995. p. 147–154.
Blumerg WE, Eisinger J, Lamola AA, Zuckerman DM. Zinc protoporphyrin level in blood determined by a portable hematofluorometer—a screening device for lead poisoning. J Lab Clin Med. 1977;89:712–3.
Jagner D, Grameli A. Potentiometric stripping analysis. Anal Chem Acta. 1976;93:19.
Sudha S, Andrade C, Anand A, Guido S, Venkataraman BV. Nitroprusside and ECS-induced retrograde amnesia. J Electro-Convuls Ther. 2001;17(1):41–4.
Murai S, Saito H, Masuda Y, Itoh T. Rapid determination of norepinephrine, dopamine, serotonin, their precursor amino acids and related metabolites in discrete brain areas of mice within ten minutes by HPLC with electrochemical detection. J Neurochem. 1988;50(2):473–9.
David O, Clark J, Voeller K. Lead and hyperactivity. Lancet. 1972;2:900–903.
Kopin IJ. Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev. 1986;37(4):333–64.
Baher M, Greengard P. Synapsin I bundles, F actin in a phosphorylation dependant manner. Nature. 1987;326:704–7.
Simons TJB. Cellular interactions between lead and calcium. Br Med Bull. 1986;42(4):431–4.
Sapolsky RM. Why stress is bad for your brain? Science. 1996;273:749–50.
McEwen B. Stress and hippocampal plasticity. Ann Rev Neurosci. 1999;22:105–22.
Flora GJ, Seth PK. Alterations in some membrane properties in rat brain following exposure to lead. Cytobios. 2000;193(403):103–9.
Kendal E, Schwartz, J. Principles of neuroscience. 4th ed. New York: McGraw Hill; 2000.
Bressler JP, Goldstein GW. Mechanisms of lead neurotoxicity. Biochem Pharmacol. 1991;41(4):479–84.
Golter, Michealson IA. Growth, behaviour, and brain catecholamines in lead- exposed neonatal rats. Science. 1975;187:359–61.
Shailesh Kumar MV, Desiraju T. Regional alterations of brain biogenic amines and GABA/glutamate levels in rats following chronic lead exposure during neonatal development. Arch Toxicol. 1990;64(4):305–14.
Rosetti ZN, Carboni S. Noradrenaline and dopamine elevations in the rat prefrontal cortex in spatial working memory. J Neurosci. 2005;25(9):2322–9.
Raymond PK, Maureen EE. Memory consolidation: Brain region and neurotransmitter specificity. Neurosci Lett. 1983;39(3): 295–300.
Zhenghan Q, Paul EG. Intrahippocampal infusions of anisomycin produce amnesia: contribution of increased release of norepinephrine, dopamine, and acetylcholine. Learn Mem. 2009;16:308–14.
Koller K, Brown T, Spurgeon A, Levy L. Recent developments in low level lead exposure and intellectual impairment in children. Environ Health Perspect. 2005;112(9):987–94.
Acknowledgments
We are greatly indebted to the Department of Neurophysiology, NIMHANS especially Dr. Rao Shankaranarayana B. S. Ph.D and Ms. Nair Deepti Ph.D, for their help in the above study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bijoor, A.R., Sudha, S. & Venkatesh, T. Neurochemical and Neurobehavioral Effects of Low Lead Exposure on the Developing Brain. Ind J Clin Biochem 27, 147–151 (2012). https://doi.org/10.1007/s12291-012-0190-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0190-2